Galcanezumab for the Management of Migraine: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Introduction Migraine is a frequent neurological condition manifested by several episodes of headache. Calcitonin gene-related peptide (CGRP) has been shown to play a key role in the pathophysiology of migraine. Galcanezumab is a monoclonal antibody that binds CGRP and inhibits its action, without a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Zaid, Ahmed, AlBatati, Saud K, AlHossan, Abdullah M, AlMatrody, Rayan A, AlGzi, Ayman, Al-Sharief, Rayan A, Alsobyani, Faris M, Almubarak, Amena F, Alatiyah, Nadeen S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755678/
https://www.ncbi.nlm.nih.gov/pubmed/33376635
http://dx.doi.org/10.7759/cureus.11621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755678/
https://www.ncbi.nlm.nih.gov/pubmed/33376635
http://dx.doi.org/10.7759/cureus.11621

Ejemplares similares